Agile Therapeutics to Join Russell 3000® and 2000® Indexes
Agile Therapeutics, Inc. (Nasdaq: AGRX) is set to be included in the Russell 3000® and 2000® Indexes effective June 29, 2020, reflecting its growth and market presence.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Agile Therapeutics, Inc. (Nasdaq: AGRX) is set to be included in the Russell 3000® and 2000® Indexes effective June 29, 2020, reflecting its growth and market presence. The Russell indexes, which track various U.S. stocks, serve as benchmarks for approximately $9 trillion in assets, utilized by institutional investors.
This inclusion could enhance liquidity and visibility for AGRX, as it becomes part of a widely followed index utilized by investment firms. Agile focuses on women's healthcare, specifically offering innovative contraceptive options like Twirla®, a non-daily prescription patch.
Positive
- Inclusion in the Russell 3000® and 2000® Indexes may enhance liquidity and visibility for AGRX.
- Russell indexes benchmark approximately $9 trillion in assets, potentially attracting institutional interest.
Negative
- None.
Details
News Market Reaction – AGRX
The recorded move for AGRX in the trading session of this news was -1.05%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PRINCETON, N.J., June 16, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that the Company will be added to the Russell 3000® and 2000® Indexes, effective after the U.S. market opens on June 29, 2020, as part of the Russell Indexes annual reconstitution.
Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Approximately
For more information on the Russell 3000® and 2000® Indexes and the Russell indexes reconstitution, go to the “Russell Reconstitution” section on the FTSE Russell website.
About Agile Therapeutics, Inc.
Agile Therapeutics is a women's healthcare company dedicated to fulfilling the unmet health needs of today’s women. Our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. Our initial product, Twirla®, (levonorgestrel and ethinyl estradiol) transdermal system is a non-daily prescription contraceptive. Twirla is based on our proprietary transdermal patch technology, called Skinfusion®, which is designed to allow drug delivery through the skin. For more information, please visit the company website at www.agiletherapeutics.com. The Company may occasionally disseminate material, nonpublic information on the Company’s website.
Follow Agile on LinkedIn and Twitter: @AgileTher.
About FTSE Russell
FTSE Russell is a leading global index provider creating and managing a wide range of indexes, data and analytic solutions to meet client needs across asset classes, style and strategies. Covering
FTSE Russell index expertise and products are used extensively by institutional and retail investors globally. Approximately
A core set of universal principles guides FTSE Russell index design and management: a transparent rules-based methodology is informed by independent committees of leading market participants. FTSE Russell is focused on index innovation and customer partnership applying the highest industry standards and embracing the IOSCO Principles. FTSE Russell is wholly owned by London Stock Exchange Group.
For more information, visit www.ftserussell.com
Contact:
Matt Riley
Investor Relations
mriley@agiletherapeutics.com